Top

Corrigendum

Split Viewer

Mol. Cells 2022; 45(7): 512-512

Published online July 31, 2022

https://doi.org/10.14348/molcells.2021.0224.e

© The Korean Society for Molecular and Cellular Biology

Corrigendum to: CHD4 Conceals Aberrant CTCF-Binding Sites at TAD Interiors by Regulating Chromatin Accessibility in Mouse Embryonic Stem Cells

Sungwook Han1,4, Hosuk Lee1,2,4, Andrew J. Lee1, Seung-Kyoon Kim3, Inkyung Jung1, Gou Young Koh2, Tae-Kyung Kim3, and Daeyoup Lee1,*

1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea, 2Center for Vascular Research, Institute for Basic Sciences, Daejeon 34141, Korea, 3Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Korea, 4These authors contributed equally to this work.

Correspondence to : daeyoup@kaist.ac.kr

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.

Body

Corrigendum to: Mol. Cells 2021; 44(11): 805-829

https://doi.org/10.14348/molcells.2021.0224


Unfortunately, Grant information has been missed out in the Data availability section of the original article. The corrected Data availability is provided below.


Data availability

The raw and processed sequencing data reported in this paper have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO: GSE172392 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE172392).

Article

Corrigendum

Mol. Cells 2022; 45(7): 512-512

Published online July 31, 2022 https://doi.org/10.14348/molcells.2021.0224.e

Copyright © The Korean Society for Molecular and Cellular Biology.

Corrigendum to: CHD4 Conceals Aberrant CTCF-Binding Sites at TAD Interiors by Regulating Chromatin Accessibility in Mouse Embryonic Stem Cells

Sungwook Han1,4, Hosuk Lee1,2,4, Andrew J. Lee1, Seung-Kyoon Kim3, Inkyung Jung1, Gou Young Koh2, Tae-Kyung Kim3, and Daeyoup Lee1,*

1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea, 2Center for Vascular Research, Institute for Basic Sciences, Daejeon 34141, Korea, 3Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Korea, 4These authors contributed equally to this work.

Correspondence to:daeyoup@kaist.ac.kr

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.

Body

Corrigendum to: Mol. Cells 2021; 44(11): 805-829

https://doi.org/10.14348/molcells.2021.0224


Unfortunately, Grant information has been missed out in the Data availability section of the original article. The corrected Data availability is provided below.


Data availability

The raw and processed sequencing data reported in this paper have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO: GSE172392 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE172392).

Mol. Cells
Jul 31, 2022 Vol.45 No.7, pp. 435~512
COVER PICTURE
Mesenchymal stem cells (MSCs) are multipotent stem cells capable of differentiating into mesodermal lineages like adipogenic, osteogenic, and chondrogenic. Alcian blue-positive extracellular matrix secreted by chondrocytes in the lacuna confirmed the chondrogenic differentiation of MSCs (Bashyal et al., pp. 479-494).

Share this article on

  • line
  • mail

Molecules and Cells

eISSN 0219-1032
qr-code Download